TITLE

Genetically Matched Human iPS Cells Reveal that Propensity for Cartilage and Bone Differentiation Differs with Clones, not Cell Type of Origin

AUTHOR(S)
Nasu, Akira; Ikeya, Makoto; Yamamoto, Takuya; Watanabe, Akira; Jin, Yonghui; Matsumoto, Yoshihisa; Hayakawa, Kazuo; Amano, Naoki; Sato, Shingo; Osafune, Kenji; Aoyama, Tomoki; Nakamura, Takashi; Kato, Tomohisa; Toguchida, Junya
PUB. DATE
January 2013
SOURCE
PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: For regenerative therapy using induced pluripotent stem cell (iPSC) technology, cell type of origin to be reprogrammed should be chosen based on accessibility and reprogramming efficiency. Some studies report that iPSCs exhibited a preference for differentiation into their original cell lineages, while others did not. Therefore, the type of cell which is most appropriate as a source for iPSCs needs to be clarified. Methodology/Principal Findings: Genetically matched human iPSCs from different origins were generated using bone marrow stromal cells (BMSCs) and dermal fibroblasts (DFs) of the same donor, and global gene expression profile, DNA methylation status, and differentiation properties into the chondrogenic and osteogenic lineage of each clone were analyzed. Although genome-wide profiling of DNA methylation suggested tissue memory in iPSCs, genes expressed differentially in BMSCs and DFs were equally silenced in our bona fide iPSCs. After cell-autonomous and induced differentiation, each iPSC clone exhibited various differentiation properties, which did not correlate with cell-of-origin. Conclusions/Significance: The reprogramming process may remove the difference between DFs and BMSCs at least for chondrogenic and osteogenic differentiation. Qualified and genetically matched human iPSC clone sets established in this study are valuable resources for further basic study of clonal differences.
ACCESSION #
85383036

 

Related Articles

  • Hsa-miR-520d Converts Fibroblasts into CD105+ Populations. Ishihara, Yoshitaka; Tsuno, Satoshi; Kuwamoto, Satoshi; Yamashita, Taro; Endo, Yusuke; Hasegawa, Junichi; Miura, Norimasa // Drugs in R&D;Dec2014, Vol. 14 Issue 4, p253 

    Background: We have previously shown that hsa-miR-520d-5p can convert cancer cells into induced pluripotent stem cells (iPSCs) or mesenchymal stem cells (MSCs) via a dedifferentiation by a demethylation mechanism. Methods: We tested the effect of miR-520d-5p on human fibroblasts to determine...

  • Efficient Generation of Integration-Free iPS Cells from Human Adult Peripheral Blood Using BCL-XL Together with Yamanaka Factors Su, Rui-Jun; Baylink, David J.; Neises, Amanda; Kiroyan, Jason B.; Meng, Xianmei; Payne, Kimberly J.; Tschudy-Seney, Benjamin; Duan, Yuyou; Appleby, Nancy; Kearns-Jonker, Mary; Gridley, Daila S.; Wang, Jun; Lau, K-H. William; Zhang, Xiao-Bing // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    The ability to efficiently generate integration-free induced pluripotent stem cells (iPSCs) from the most readily available source—peripheral blood—has the potential to expedite the advances of iPSC-based therapies. We have successfully generated integration-free iPSCs from cord...

  • Generation of Corneal Epithelial Cells from Induced Pluripotent Stem Cells Derived from Human Dermal Fibroblast and Corneal Limbal Epithelium. Hayashi, Ryuhei; Ishikawa, Yuki; Ito, Miyuki; Kageyama, Tomofumi; Takashiba, Kuniko; Fujioka, Tsuyoshi; Tsujikawa, Motokazu; Miyoshi, Hiroyuki; Yamato, Masayuki; Nakamura, Yukio; Nishida, Kohji; Morishita, Ryuichi // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Induced pluripotent stem (iPS) cells can be established from somatic cells. However, there is currently no established strategy to generate corneal epithelial cells from iPS cells. In this study, we investigated whether corneal epithelial cells could be differentiated from iPS cells. We tested 2...

  • Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Bar-Nur, Ori; Verheul, Cassandra; Sommer, Andreia G; Brumbaugh, Justin; Schwarz, Benjamin A; Lipchina, Inna; Huebner, Aaron J; Mostoslavsky, Gustavo; Hochedlinger, Konrad // Nature Biotechnology;Jul2015, Vol. 33 Issue 7, p761 

    Brief expression of pluripotency-associated factors such as Oct4, Klf4, Sox2 and c-Myc (OKSM), in combination with differentiation-inducing signals, has been reported to trigger transdifferentiation of fibroblasts into other cell types. Here we show that OKSM expression in mouse fibroblasts...

  • Prospect of Stem Cells in Bone Tissue Engineering: A Review. Yousefi, Azizeh-Mitra; James, Paul F.; Akbarzadeh, Rosa; Subramanian, Aswati; Flavin, Conor; Oudadesse, Hassane // Stem Cells International;1/6/2016, p1 

    Mesenchymal stem cells (MSCs) have been the subject of many studies in recent years, ranging from basic science that looks into MSCs properties to studies that aim for developing bioengineered tissues and organs. Adult bone marrow-derived mesenchymal stem cells (BM-MSCs) have been the focus of...

  • Production of Embryonic and Fetal-Like Red Blood Cells from Human Induced Pluripotent Stem Cells. Chan-Jung Chang; Mitra, Koyel; Koya, Mariko; Velho, Michelle; Desprat, Romain; Lenz, Jack; Bouhassira, Eric E. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    We have previously shown that human embryonic stem cells can be differentiated into embryonic and fetal type of red blood cells that sequentially express three types of hemoglobins recapitulating early human erythropoiesis. We report here that we have produced iPS from three somatic cell types:...

  • Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs). Spinelli, valentina; Guillot, Pascale v.; Coppi, Paolo De // Organogenesis;Apr-Jun2013, Vol. 9 Issue 2, p101 

    Introduction: (1) Human embryonic stem (eS) cells are pluripotent but are diicult to be used for therapy because of immunological, oncological and ethical barriers. (2) Pluripotent cells exist in vivo, i.e., germ cells and epiblast cells but cannot be isolated without sacriicing the developing...

  • Involvement of MicroRNAs in Regulation of Osteoblastic Differentiation in Mouse Induced Pluripotent Stem Cells. Okamoto, Hideharu; Matsumi, Yoshiaki; Hoshikawa, Yoshiko; Takubo, Kazuko; Ryoke, Kazuo; Shiota, Goshi; Navarro, Alfons // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Backgoround: MicroRNAs (miRNAs), which regulate biological processes by annealing to the 39-untranslated region (39-UTR) of mRNAs to reduce protein synthesis, have been the subject of recent attention as a key regulatory factor in cell differentiation. The effects of some miRNAs during...

  • Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart. Buccini, Stephanie; Haider, Khawaja; Ahmed, Rafeeq; Jiang, Shujia; Ashraf, Muhammad // Basic Research in Cardiology;Nov2012, Vol. 107 Issue 6, p1 

    The strategy to reprogram somatic stem cells to pluripotency status has provided an alternative source of surrogate ES cells (ESC). We report efficient reprogramming of multipotent bone marrow (BM) mesenchymal stem cells (MSC) to pluripotent status and the resultant MSC derived iPS cells (MiPS)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics